| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme
|
Edoka, Ijeoma
|
|
|
39 |
2 |
p. 412-422
|
article
|
| 2 |
Adapting and piloting a vaccine hesitancy questionnaire in rural Guatemala
|
Williams, Joshua T.B.
|
|
|
39 |
2 |
p. 180-184
|
article
|
| 3 |
Adjustments for oral fluid quality and collection methods improve prediction of circulating tetanus antitoxin: Approaches for correcting antibody concentrations detected in a non-invasive specimen
|
Garrison-Desany, Henri
|
|
|
39 |
2 |
p. 423-430
|
article
|
| 4 |
A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan
|
Kitano, Taito
|
|
|
39 |
2 |
p. 343-349
|
article
|
| 5 |
Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis
|
Sanftenberg, Linda
|
|
|
39 |
2 |
p. 185-196
|
article
|
| 6 |
A systematic review of factors that influence the acceptability of vaccines among Canadians
|
Gates, Allison
|
|
|
39 |
2 |
p. 222-236
|
article
|
| 7 |
Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model
|
Maiti, Suhrid
|
|
|
39 |
2 |
p. 380-393
|
article
|
| 8 |
Broad cross-national public support for accelerated COVID-19 vaccine trial designs
|
Broockman, David
|
|
|
39 |
2 |
p. 309-316
|
article
|
| 9 |
Consumer acceptability and validity of m-Health for the detection of adverse events following immunization – The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial
|
Gold, M.S.
|
|
|
39 |
2 |
p. 237-246
|
article
|
| 10 |
Cost-effectiveness of live-attenuated influenza vaccination among school-age children
|
Wenzel, Natasha S.
|
|
|
39 |
2 |
p. 447-456
|
article
|
| 11 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
2 |
p. IFC
|
article
|
| 12 |
Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine
|
Liu, Cunbao
|
|
|
39 |
2 |
p. 263-271
|
article
|
| 13 |
Efficacy of m-Health for the detection of adverse events following immunization – The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial
|
Gold, M.S.
|
|
|
39 |
2 |
p. 332-342
|
article
|
| 14 |
From bad to worse II: Risk amplification of the HPV vaccine on Facebook
|
Luisi, Monique L.R.
|
|
|
39 |
2 |
p. 303-308
|
article
|
| 15 |
HED: Trying to work our way back to normal
|
Davis, Jennifer
|
|
|
39 |
2 |
p. 169-170
|
article
|
| 16 |
How to ensure we can track and trace global use of COVID-19 vaccines?
|
Vander Stichele, Robert H.
|
|
|
39 |
2 |
p. 176-179
|
article
|
| 17 |
Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands
|
Peckeu, L.
|
|
|
39 |
2 |
p. 431-437
|
article
|
| 18 |
In-depth analysis of pneumococcal serotypes in Belgian children (2015–2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease
|
Desmet, Stefanie
|
|
|
39 |
2 |
p. 372-379
|
article
|
| 19 |
Individual preferences for COVID-19 vaccination in China
|
Leng, Anli
|
|
|
39 |
2 |
p. 247-254
|
article
|
| 20 |
Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: A new promising vaccine against visceral leishmaniasis
|
de Oliveira Emerick, Sabrina
|
|
|
39 |
2 |
p. 282-291
|
article
|
| 21 |
Locked Down
|
Soreca, Vincent
|
|
|
39 |
2 |
p. 167-168
|
article
|
| 22 |
Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines
|
Haveri, Anu
|
|
|
39 |
2 |
p. 402-411
|
article
|
| 23 |
Meningococcal vaccination in patients with newly diagnosed asplenia in the United States
|
Ghaswalla, Parinaz K.
|
|
|
39 |
2 |
p. 272-281
|
article
|
| 24 |
Mobile phone reminders for enhancing uptake, completeness and timeliness of routine childhood immunization in low and middle income countries: A systematic review and meta-analysis
|
Yunusa, Umar
|
|
|
39 |
2 |
p. 209-221
|
article
|
| 25 |
National vaccine coverage trends and funding in Latin America and the Caribbean
|
Llau, Anthoni F
|
|
|
39 |
2 |
p. 317-323
|
article
|
| 26 |
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
|
Ura, Takehiro
|
|
|
39 |
2 |
p. 197-201
|
article
|
| 27 |
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
|
Zacharia, Athina
|
|
|
39 |
2 |
p. 292-302
|
article
|
| 28 |
PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness
|
Ghiga, Ioana
|
|
|
39 |
2 |
p. 364-371
|
article
|
| 29 |
Preclinical evaluation of tuberculosis vaccine candidates: Is it time to harmonize study design and readouts for prioritizing their development?
|
Flores-Valdez, Mario Alberto
|
|
|
39 |
2 |
p. 173-175
|
article
|
| 30 |
Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
|
Maykin, Melanie M.
|
|
|
39 |
2 |
p. 171-172
|
article
|
| 31 |
Priority allocation of pandemic influenza vaccines in Australia – Recommendations of 3 community juries
|
Degeling, C.
|
|
|
39 |
2 |
p. 255-262
|
article
|
| 32 |
Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
|
Majed, Laureen
|
|
|
39 |
2 |
p. 438-446
|
article
|
| 33 |
Safety of maternal pertussis vaccination on pregnancy and birth outcomes: A prospective cohort study
|
Mohammed, Hassen
|
|
|
39 |
2 |
p. 324-331
|
article
|
| 34 |
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials
|
Dulin, Nicholas
|
|
|
39 |
2 |
p. 202-208
|
article
|
| 35 |
Trends in the uptake of pediatric measles-containing vaccine in the United States: A Disneyland effect?
|
Doll, Margaret K.
|
|
|
39 |
2 |
p. 357-363
|
article
|
| 36 |
Understanding the messages and motivation of vaccine hesitant or refusing social media influencers
|
Leader, Amy E.
|
|
|
39 |
2 |
p. 350-356
|
article
|
| 37 |
Vaccination with chimeric protein induces protection in murine model against ascariasis
|
de Castro, Joseane C.
|
|
|
39 |
2 |
p. 394-401
|
article
|
Journal description